AI technologies are making their way into endoscopic procedures, enhancing diagnosis and patient care. The U.S., Europe, and Japan are leading this innovative change. AI empowers endoscopy with advanced imaging analysis and real-time insights, improving clinical outcomes.
Europe embraces AI-driven endoscopy solutions, fueled by rise in healthcare investments, increase in gastrointestinal diseases, and supportive regulations. Countries aim to integrate AI to boost diagnostic accuracy and optimize treatments.
This shift reflects Europe's commitment to advancing healthcare through technology and driving market development.
Continued collaborative efforts between healthcare providers and technology companies, and robust research and development, are expected to drive significant U.S., Europe, and Japan AI in endoscopy market growth in the next few years. This synergy promises to transform endoscopic practices and patient care.
Artificial intelligence (AI) is an important topic in clinical medicine, mainly in gastrointestinal (GI) endoscopy. AI has advanced the quality of gastrointestinal endoscopy at all levels. AI in endoscopy is anticipated to recompense for human errors and limitations by refining accuracy, consistency, and speed, resulting in more efficient and high-quality endoscopic procedures.
AI reveals excellent results in diagnostic and therapeutic endoscopy across the entire GI tract. The use of AI technology in gastrointestinal (GI) endoscopy is likely to reduce inter-operator variability, improve diagnostic accuracy, and help in making quick but accurate therapeutic decisions on the spot.
Attribute | Detail |
---|---|
Driver |
|
The applications of AI has been gaining popularity in endoscopy in recent years due to its capacity to improve the procedure accuracy and efficiency. Colorectal cancer, which affects the rectum and colon, is the most common cause of cancer-related mortality globally.
Its incidence has risen over time, driving the need for effective screening and diagnostic techniques for early detection. Endoscopy, which involves inserting a small camera into the colon or rectum, is one of the most effective ways to detect colorectal cancer.
Artificial intelligence methods can analyze images and videos of the colon or rectum in real time, detecting and highlighting any abnormalities that the human eye may miss.
Colorectal cancer is the third most commonly diagnosed cancer in the world, accounting for 10% of all cancer cases. It is also the second leading cause of cancer deaths, accounting for approximately 9.4% of all cancer-related deaths in 2020.
The adenoma detection rate (ADR), or the rate at which a doctor detects precancerous polyps during a standard screening colonoscopy for patients over 50 years old, is inversely related to the risk of developing CRC after colonoscopy.
On average, a 1% increase in ADR reduces the risk of CRC by 3%. As a result, assisting doctors during endoscopy procedures to improve the detection rate of adenomas and polyps, thus ultimately lowering CRC rates, is boosting the U.S., Europe, and Japan AI in endoscopy industry growth.
In the U.S., over 20 million gastrointestinal endoscopies are carried out annually, according to the National Institutes of Health. Furthermore, organizations such as the FDA are increasingly supporting the use of AI in healthcare, including endoscopy.
Simplifying regulatory processes can spur innovation and investment in AI-based endoscopy solutions, potentially driving the growth of this market in the U.S. during the projected period.
The CADe segment is projected to gain significant market share during the forecast period. The U.S. is an early adopter of new technologies, and the same applies to AI-assisted diagnosis and treatment, including CADe, which is the most used software in endoscopy.
AI technology is quickly gaining ground in Europe as businesses become more aware of its advantages and numerous industry players drive innovation. For example, Fujifilm's CAD EYE feature, which uses AI to detect and analyze colon polyps in real time, has been available for commercial use in Europe since 2020.
A surge in development of AI-powered products and software, many of which are used in endoscopic procedures, is fueling market progress in Europe. AI algorithms have been integrated into endoscopic devices, which has enhanced their performance and precision, allowing doctors to make better judgments during procedures.
Japan has one of the highest aging populations globally, resulting in a rise in prevalence of gastrointestinal diseases such as colorectal cancer. Primary detection of gastrointestinal diseases is crucial for active treatment and improving patient outcomes.
In Japan, clinical studies in surgery are being directed using large-scale data sets. Currently, insurance covers 14.3 million cases of gastrointestinal endoscopy each year. Moreover, the number of gastrointestinal malignancies treated with gastrointestinal endoscopy is growing.
Japan's strong technological expertise and the demanding healthcare needs driven by its aging population, has led to major advancements in AI applications in endoscopy, offering lucrative opportunities for market expansion.
Companies such as Fujifilm and Olympus are dynamically contributing to this field; trends such as multi-modal imaging and personalized medicine are modelling the future of AI in endoscopy in Japan.
Leading players in the market are focusing on strategies such as new product launches, mergers, partnerships, and collaborations to strengthen their position. They are following the latest U.S., Europe, and Japan AI in endoscopy market trends to avail lucrative revenue opportunities.
Medtronic plc, Wision A.I., Olympus Corporation. Ltd, Fujifilm Corporation. Pentax Corporation, NEC Corporation, Magentiq Eye Inc., ENDOANGEL Medical Technology Co., Ltd., Waycen Inc., and Iterative Scopes are the prominent U.S., Europe, and Japan AI in endoscopy market manufacturers.
Prominent players have been profiled in the U.S., Europe, and Japan AI in endoscopy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
Attribute | Detail |
---|---|
Size in 2022 | US$ 46.4 Mn |
Forecast (Value) in 2031 | More than US$ 367.5 Mn |
Growth Rate (CAGR) | 26.4% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape | Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials |
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
It was valued at US$ 46.4 Mn in 2022
It is projected to reach more than US$ 367.5 Mn by the end of 2031
The CAGR is anticipated to be 26.4% from 2023 to 2031
The benefits of these innovative technologies are increasingly being recognizing by healthcare providers and patients alike
CADe segment accounted for major share in 2022 based on CAD
Europe is expected to account for major share during the forecast period
Medtronic plc, Wision A.I., Olympus Corporation Ltd, Fujifilm Corporation, Pentax Corporation, NEC Corporation, Magentiq Eye Inc., ENDOANGEL Medical Technology Co., Ltd., Waycen Inc., and Iterative Scopes
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S., Europe, and Japan AI in Endoscopy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S., Europe, and Japan AI in Endoscopy Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Product/Brand Analysis
5.3. Key Industry Events (Mergers & Acquisitions, Partnerships, and Product Launches)
5.4. Total number of AI Endoscopy Devices Sold by Country
5.5. COVID-19 Impact Analysis
5.6. Impact of AI in Endoscopy on Different Type of Cancer Detection (Colon, Barrett’s Esophagus, Gastric)
6. U.S. AI in Endoscopy Market Analysis and Forecast
6.1. Introduction
6.1.1. Key Findings
6.2. Market Value Forecast, by Type, 2017-2031
6.2.1. Product
6.2.2. Service
6.3. Market Value Forecast, by CAD, 2017-2031
6.3.1. CADe
6.3.2. CADx
6.3.3. CADe/CADx
6.4. Market Value Forecast, by Application, 2017-2031
6.4.1. Polyps Detection
6.4.2. Bleeding Detection
6.4.3. Early Cancer Identification
6.4.4. Cancer Staging
6.4.5. Polyp Sizing
6.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
6.5. Market Value Forecast, by End-user, 2017-2031
6.5.1. Hospitals
6.5.2. Ambulatory Surgical Centers
6.5.3. Specialty Clinics
6.6. Market Attractiveness Analysis
6.6.1. By Type
6.6.2. By CAD
6.6.3. By Application
6.6.4. By End-user
7. Europe AI in Endoscopy Market Analysis and Forecast
7.1. Introduction
7.1.1. Key Findings
7.2. Market Value Forecast, by Type, 2017-2031
7.2.1. Product
7.2.2. Service
7.3. Market Value Forecast, by CAD, 2017-2031
7.3.1. CADe
7.3.2. CADx
7.3.3. CADe/CADx
7.4. Market Value Forecast, by Application, 2017-2031
7.4.1. Polyps Detection
7.4.2. Bleeding Detection
7.4.3. Early Cancer Identification
7.4.4. Cancer Staging
7.4.5. Polyp Sizing
7.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
7.5. Market Value Forecast, by End-user, 2017-2031
7.5.1. Hospitals
7.5.2. Ambulatory Surgical Centers
7.5.3. Specialty Clinics
7.6. Market Value Forecast, by Country/Sub-region, 2017-2031
7.6.1. Germany
7.6.2. U.K.
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Rest of Europe
7.7. Market Attractiveness Analysis
7.7.1. By Type
7.7.2. By CAD
7.7.3. By Application
7.7.4. By End-user
7.7.5. By Country/Sub-region
8. Japan AI in Endoscopy Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017-2031
8.2.1. Product
8.2.2. Service
8.3. Market Value Forecast, by CAD, 2017-2031
8.3.1. CADe
8.3.2. CADx
8.3.3. CADe/CADx
8.4. Market Value Forecast, by Application, 2017-2031
8.4.1. Polyps Detection
8.4.2. Bleeding Detection
8.4.3. Early Cancer Identification
8.4.4. Cancer Staging
8.4.5. Polyp Sizing
8.4.6. Others (Polyps Characterization, Quality Indicators, etc.)
8.5. Market Value Forecast, by End-user, 2017-2031
8.5.1. Hospitals
8.5.2. Ambulatory Surgical Centers
8.5.3. Specialty Clinics
8.6. Market Attractiveness Analysis
8.6.1. By Type
8.6.2. By CAD
8.6.3. By Application
8.6.4. By End-user
9. Competition Landscape
9.1. U.S. Europe, and Japan AI in Endoscopy Market, Company Share Analysis (2022)
9.2. Company Profiles
9.2.1. Medtronic plc
9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.1.4. SWOT Analysis
9.2.1.5. Strategic Overview
9.2.2. Wision A.I.
9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.2.4. SWOT Analysis
9.2.2.5. Strategic Overview
9.2.3. Olympus Corporation
9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.3.4. SWOT Analysis
9.2.3.5. Strategic Overview
9.2.4. ENDOANGEL Medical Technology Co., Ltd.
9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.4.4. SWOT Analysis
9.2.4.5. Strategic Overview
9.2.5. Fujifilm Corporation
9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.5.4. SWOT Analysis
9.2.5.5. Strategic Overview
9.2.6. Pentax Corporation
9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.6.4. SWOT Analysis
9.2.6.5. Strategic Overview
9.2.7. NEC Corporation
9.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.7.2. Product Portfolio
9.2.7.3. Financial Overview
9.2.7.4. SWOT Analysis
9.2.7.5. Strategic Overview
9.2.8. Magentiq Eye
9.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.8.2. Product Portfolio
9.2.8.3. Financial Overview
9.2.8.4. SWOT Analysis
9.2.8.5. Strategic Overview
9.2.9. Waycen Inc.
9.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.9.2. Product Portfolio
9.2.9.3. Financial Overview
9.2.9.4. SWOT Analysis
9.2.9.5. Strategic Overview
9.2.10. Iterative Scopes
9.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.10.2. Product Portfolio
9.2.10.3. Financial Overview
9.2.10.4. SWOT Analysis
9.2.10.5. Strategic Overview
List of Tables
Table 01: U.S. AI in Endoscopy Market Value (US$ Mn) Forecast, by Type, 2019-2031
Table 02: U.S. AI in Endoscopy Market Value (US$ Mn) Forecast, by CAD, 2019-2031
Table 03: U.S. AI in Endoscopy Market Value (US$ Mn) Forecast, by Application, 2019-2031
Table 04: U.S. AI in Endoscopy Market Value (US$ Mn) Forecast, by End-user, 2019-2031
Table 05: Europe AI in Endoscopy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019-2031
Table 06: Europe AI in Endoscopy Market Value (US$ Mn) Forecast, by Type, 2019-2031
Table 07: Europe AI in Endoscopy Market Value (US$ Mn) Forecast, by CAD, 2019-2031
Table 08: Europe AI in Endoscopy Market Value (US$ Mn) Forecast, by Application, 2019-2031
Table 09: Europe AI in Endoscopy Market Value (US$ Mn) Forecast, by End-user, 2019-2031
Table 10: Japan AI in Endoscopy Market Value (US$ Mn) Forecast, by Type, 2019-2031
Table 11: Japan AI in Endoscopy Market Value (US$ Mn) Forecast, by CAD, 2019-2031
Table 12: Japan AI in Endoscopy Market Value (US$ Mn) Forecast, by Application, 2019-2031
Table 13: Japan AI In Endoscopy Market Value (US$ Mn) Forecast, by End-user, 2019-2031
List of Figures
Figure 01: U.S., Europe, and Japan AI in Endoscopy Market Value (US$ Mn) Forecast, 2019-2031
Figure 02: U.S., Europe, and Japan AI in Endoscopy Market Value Share, by Type, 2022
Figure 03: U.S., Europe, and Japan AI in Endoscopy Market Value Share, by CAD, 2022
Figure 04: U.S., Europe, and Japan AI in Endoscopy Market Value Share, by Application, 2022
Figure 05: U.S., Europe, and Japan AI in Endoscopy Market Value Share, by End-user, 2022
Figure 06: U.S. AI in Endoscopy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019-2031
Figure 07: U.S. AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Type, 2022 and 2031
Figure 08: U.S. AI in Endoscopy Market Attractiveness Analysis, by Type, 2023-2031
Figure 09: U.S. AI in Endoscopy Market Value (US$ Mn) Share Analysis, by CAD, 2022 and 2031
Figure 10: U.S. AI in Endoscopy Market Attractiveness Analysis, by CAD, 2023-2031
Figure 11: U.S. AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 12: U.S. AI in Endoscopy Market Attractiveness Analysis, by Application, 2023-2031
Figure 13: U.S. AI in Endoscopy Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 14: U.S. AI in Endoscopy Market Attractiveness Analysis, by End-user, 2023-2031
Figure 15: Europe AI in Endoscopy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019-2031
Figure 16: Europe AI in Endoscopy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 17: Europe AI in Endoscopy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019-2031
Figure 18: Europe AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Type, 2022 and 2031
Figure 19: Europe AI in Endoscopy Market Attractiveness Analysis, by Type, 2023-2031
Figure 20: North America AI in Endoscopy Market Value (US$ Mn) Share Analysis, by CAD, 2022 and 2031
Figure 21: North America AI in Endoscopy Market Attractiveness Analysis, by CAD, 2023-2031
Figure 22: Europe AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 23: Europe AI in Endoscopy Market Attractiveness Analysis, by Application, 2023-2031
Figure 24: Europe AI in Endoscopy Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 25: Europe AI in Endoscopy Market Attractiveness Analysis, by End-user, 2023-2031
Figure 26: Japan AI in Endoscopy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019-2031
Figure 27: Japan AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Type, 2022 and 2031
Figure 28: Japan AI in Endoscopy Market Attractiveness Analysis, by Type, 2023-2031
Figure 29: Japan AI in Endoscopy Market Value (US$ Mn) Share Analysis, by CAD, 2022 and 2031
Figure 30: Japan AI in Endoscopy Market Attractiveness Analysis, by CAD, 2023-2031
Figure 31: Japan AI in Endoscopy Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 32: Japan AI in Endoscopy Market Attractiveness Analysis, by Application, 2023-2031
Figure 33: Japan AI in Endoscopy Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 34: Japan AI in Endoscopy Market Attractiveness Analysis, by End-user, 2023-2031
Figure 35: AI in Endoscopy Market: Company Share Analysis, 2022